|
?:authorAffiliation
|
-
[\'Saint Luke\'s Mid America Heart Institute, University of Missouri, Kansas City, Missouri, USA.\', \'The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.\', \'Academic Research Organization - Hospital Israelita Albert Einstein, São Paulo, Brazil.\', \'The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.\', \'National University of Cordoba, Córdoba, Argentina.\', \'Experimental Medicine & Immunotherapeutics Division, Department of Medicine, University of Cambridge, Cambridge, UK.\', \'Division of Cardiac Surgery, Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute of St. Michael\'s Hospital, Toronto, Ontario, Canada.\', \'Department of Surgery, University of Toronto, Toronto, Ontario, Canada.\', \'Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.\', \'Max Super Speciality Hospital, New Delhi, India.\', \'Washington University School of Medicine, St Louis, Missouri, USA.\', \'Late-Stage Development, CVRM, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.\', \'Late-Stage Development, CVRM, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}